Mycophenolate Sodium DR (Generic for Myfortic)
Description
Introducing Mycophenolate Sodium Anti-Transplant Delayed Release Tablet formulated to the Myfortic standard—a sustained‑release product designed to inhibit lymphocyte proliferation with improved gastrointestinal tolerability. Experience enhanced graft protection, improved metabolic stability, and superior patient outcomes with this advanced, targeted delayed release tablet therapy.
Frequently Asked Questions
Organ Transplant
Form
Strength
